Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.07.2023 | Case report

Erenumab/ibuprofen/sumatriptan

Treatment failure and constipation: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Uzun S, et al. A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?. Frontiers in Neurology 14: Jan 2023. Available from: URL: http://www.frontiersin.org/Neurology Uzun S, et al. A case report of a chronic migraine patient treated with three different anti-CGRP monoclonal antibodies: which parameters better represent the efficacy?. Frontiers in Neurology 14: Jan 2023. Available from: URL: http://​www.​frontiersin.​org/​Neurology
Metadaten
Titel
Erenumab/ibuprofen/sumatriptan
Treatment failure and constipation: case report
Publikationsdatum
01.07.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-42749-y

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Osimertinib

Case report

Methotrexate

Case report

Antineoplastics